A Multiple-Ascending Dose Study in Type 2 Diabetes Mellitus Patients
PHASE1
The study drug LY2393910 is being evaluated as a possible treatment for dia...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Efficacy and Safety Comparison of Cofrogliptin Add-on Versus Metformin Dose-escalation in Type 2 Diabetes Patients Inadequately Controlled With SGLT-2 Inhibitors Plus Low-Dose Metformin:A Multicenter, Open-Label Trial
NA
The aim of this study is to evaluate the change in glycated hemoglobin (HbA...
Status
Recruiting
Location
Second Affiliated Hospital, School of Medicine, Zhejiang University
A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor
PHASE3
This study is a multicenter, randomized, open-label, parallel-group, phase ...